Status:
COMPLETED
Oral NSAI Versus Paracetamol or Placebo as a Second Line Treatment for Renal Colics
Lead Sponsor:
University of Monastir
Conditions:
Renal Colic
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Outpatients treatment with NSAI in renal colics has not been well investigated and there is no clear recommendations regarding this matter. The aim of this study is to determine if an oral NSAI treat...
Detailed Description
Renal colic (RC)are a frequent cause of consultation in the emergency departement (ED). They count for approximatively 20% of patients presenting to the ED with severe acute onset abdominal pain. Th...
Eligibility Criteria
Inclusion
- Over 18 years old
- Consenting to participate in the study
- Patients treated in the ED for RC
- No contraindications of NSAI treatment
Exclusion
- Patients excluded from the first phase of the study
- Contraindication of NSAI treatment
- Patients non reachable by telephone call
- Patients that did not receive or use the treatment
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT02304783
Start Date
January 1 2014
End Date
December 1 2021
Last Update
April 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emergency Department of University Hospital of Monastir
Monastir, Tunisia, 5050